Lone Pine Capital Surges Position in Michael Kors Holdings Ltd (KORS)

According to a new filing with the Securities and Exchange commission, Stephen Mandel’s Lone Pine Capital has almost doubled its exposure to Michael Kors Holdings Ltd (NYSE:KORS). The fund disclosed holding around 11.29 million shares of Michael Kors, versus 6.11 million owned earlier. The new stake amasses 5.5% of the outstanding stock.

LONE PINE CAPITAL

The stock of Michael Kors Holdings Ltd (NYSE:KORS) has gained over 15% since the beginning of the year. The company recently disclosed its financial results for the third quarter of its fiscal 2014, posting an almost 60% increase on the year in revenues to $1.0 billion. The retail net sales went up by an annual 51% to $503.4 million. On the back of sales and revenues increase, the company’s net profit surged to $229.6 million, or $1.11 per diluted share, from $130 million, or $0.64 per share a year earlier. For the full fiscal 2014, analysts expect the company to report EPS of $3.11 and revenues worth $3.2 billion.

Recently, Michael Kors Holdings Ltd (NYSE:KORS) entered into an agreement with Luxottica Group SpA (ADR) (NYSE:LUX) for the Michael Kors Collection of eyewear. The first collection will be launched at the beginning of next year, and the partnership between the two companies will last 10 years, Michael Kors said in a press release.

In the previous round of 13F filings, Andreas Halvorsen‘s Viking Global disclosed ownership of 8.34 million shares of Michael Kors Holdings Ltd (NYSE:KORS). Donald Chiboucis‘ Columbus Circle Investors and Rob Citrone‘s Discovery Capital Management held around 1.82 million and 1.71 million shares respectively.

At the beginning of March, Lone Pine reported significantly raising its position in SouFun Holdings Limited (NYSE:SFUN) to 3.7 million shares, equal to 6.4% of the outstanding stock, from 45,000 shares held previously. The fund also initiated a stake in LPL Financial Holdings Inc (NASDAQ:LPLA), during the previous quarter, currently holding 6.52 million shares, equal to 6.4% of the stock.

Disclosure: none

Recommended Reading:

Stay Away From Stephen Mandel’s Top Stock Picks

Billionaires Steven Cohen and Stephen Mandel Disclose Huge Stakes in Lumber Liquidators Holdings Inc (LL)

Lone Pine Capital Discloses New 6.4% Stake in SBA Communications Corporation (SBAC)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!